Physician profile
Han L Tan
NPI 1629011440
$12,500.33
in general payments reported to CMS, 2019-2025
41 companies · $2,195 in 2025
The $2,195 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,483 · 2020: $856 · 2021: $1,304 · 2022: $1,734 · 2023: $1,549 · 2024: $2,380 · 2025: $2,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,098 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,098.41 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,386.21 | 2019-2025 | Jardiance |
| Pfizer INC. | $1,323.92 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $999.54 | 2019-2025 | |
| Amgen INC. | $969.86 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $759.81 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $700.08 | 2019-2025 | Camzyos, Eliquis |
| Itamar Medical INC | $655.11 | 2021-2025 | Watchpatone |
| Janssen Pharmaceuticals, INC | $585.09 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $584.55 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $509.13 | 2022-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $457.73 | 2019-2022 | |
| Zoll Respicardia, INC. | $307.11 | 2021-2024 | Remede System |
| Abbott Laboratories | $284.25 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Amplatzer |
| Atricure, INC. | $274.93 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $274.69 | 2023-2025 | Optimizer, Optimizer |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.